HMGB1 and cancer: Sustained HMGB1 signaling limits chemotherapeutic responses in tumor cells, promoting resistance via enhanced autophagy, inhibiting both intrinsic and extrinsic-mediated apoptotic pathways in cancer cells (18–21).